{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:57:38Z","timestamp":1792155458675,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI114398"],"award-info":[{"award-number":["T32AI114398"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI069470"],"award-info":[{"award-number":["UM1AI069470"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"U.S. Agency for International Development","doi-asserted-by":"crossref","award":["AID-OAA-A-15-00045 (PROMISE)"],"award-info":[{"award-number":["AID-OAA-A-15-00045 (PROMISE)"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000200","name":"U.S. Agency for International Development","doi-asserted-by":"crossref","award":["7200AA21CA00011 (MOSAIC)"],"award-info":[{"award-number":["7200AA21CA00011 (MOSAIC)"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Res Policy Sys"],"DOI":"10.1186\/s12961-024-01240-5","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T11:33:30Z","timestamp":1732534410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Leveraging international stakeholders\u2019 experiences with oral PrEP costs to accelerate implementation of the monthly dapivirine vaginal ring: A qualitative study"],"prefix":"10.1186","volume":"22","author":[{"given":"Craig J.","family":"Heck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Kripke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Torres-Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiammetta","family":"Bozzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Obermeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kibret","family":"Yohannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Deacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Quigee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wiant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Forsythe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Malati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena E.","family":"Sobieszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delivette","family":"Castor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"1240_CR1","unstructured":"Joint United Nations Programme on HIV\/AIDS. The urgency of now: AIDS at a crossroads. Geneva; 2024."},{"key":"1240_CR2","volume-title":"The Path That Ends AIDS: 2023 UNAIDS Global AIDS Update","author":"The Joint United Nations Programme on HIV\/AIDS","year":"2023","unstructured":"The Joint United Nations Programme on HIV\/AIDS. The path that ends AIDS: 2023 UNAIDS Global AIDS Update. Geneva: UNAIDS; 2023."},{"key":"1240_CR3","volume-title":"Global AIDS update 2021: confronting inequalities \u2013 lessons for pandemic responses from 40 years of AIDS","author":"Joint United Nations Programme on HIV\/AIDS","year":"2021","unstructured":"Joint United Nations Programme on HIV\/AIDS. Global AIDS update 2021: confronting inequalities \u2013 lessons for pandemic responses from 40 years of AIDS. Geneva: Switzerland; 2021."},{"key":"1240_CR4","unstructured":"The World Health Organization. WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection 2021 [cited 2023 July 23]. Available from: https:\/\/www.who.int\/news\/item\/26-01-2021-who-recommends-the-dapivirine-vaginal-ring-as-a-new-choice-for-hiv-prevention-for-women-at-substantial-risk-of-hiv-infection."},{"key":"1240_CR5","unstructured":"The World Health Organization. Guidelines on long-acting injectable cabotegravir for HIV prevention. 2022."},{"key":"1240_CR6","unstructured":"World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. World Health Organization; 2015."},{"key":"1240_CR7","unstructured":"AVAC. 2023 Q4 Global PrEP Tracker 204 [cited 2024 March 16]. Available from: https:\/\/www.prepwatch.org\/resources\/global-prep-tracker\/."},{"issue":"5","key":"1240_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154893","volume":"11","author":"J Stover","year":"2016","unstructured":"Stover J, Bollinger L, Izazola JA, Loures L, DeLay P, Ghys PD, et al. What is required to end the AIDS epidemic as a public health threat by 2030? The cost and impact of the fast-track approach. PLoS ONE. 2016;11(5): e0154893.","journal-title":"PLoS ONE"},{"key":"1240_CR9","volume-title":"In Danger: UNAIDS Global AIDS Update 2022","author":"The Joint United Nations Programme on HIV\/AIDS","year":"2022","unstructured":"The Joint United Nations Programme on HIV\/AIDS. In Danger: UNAIDS Global AIDS Update 2022. Geneva: UNAIDS; 2022."},{"key":"1240_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26110","volume":"26","author":"D Castor","year":"2023","unstructured":"Castor D, Heck CJ, Quigee D, Telrandhe NV, Kui K, Wu J, et al. Implementation and resource needs for long-acting PrEP in low-and middle-income countries: a scoping review. J Int AIDS Soc. 2023;26: e26110.","journal-title":"J Int AIDS Soc"},{"issue":"7","key":"1240_CR11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s40273-022-01231-w","volume":"41","author":"S Torres-Rueda","year":"2023","unstructured":"Torres-Rueda S, Terris-Prestholt F, Gafos M, Indravudh PP, Giddings R, Bozzani F, et al. Health economics research on non-surgical biomedical HIV prevention: identifying gaps and proposing a way forward. Pharmacoeconomics. 2023;41(7):787\u2013802.","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"1240_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s40273-022-01223-w","volume":"41","author":"FM Bozzani","year":"2023","unstructured":"Bozzani FM, Terris-Prestholt F, Quaife M, Gafos M, Indravudh PP, Giddings R, et al. Costs and cost-effectiveness of biomedical, non-surgical HIV prevention interventions: a systematic literature review. Pharmacoeconomics. 2023;41(5):467\u201380.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"1240_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25390","volume":"22","author":"KK Case","year":"2019","unstructured":"Case KK, Gomez GB, Hallett TB. The impact, cost and cost-effectiveness of oral pre-exposure prophylaxis in sub-Saharan Africa: a scoping review of modelling contributions and way forward. J Int AIDS Soc. 2019;22(9): e25390.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"1240_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.9745\/GHSP-D-15-00300","volume":"4","author":"AB Lipsky","year":"2016","unstructured":"Lipsky AB, Gribble JN, Cahaelen L, Sharma S. Partnerships for policy development: a case study from Uganda\u2019s costed implementation plan for family planning. Global Health Sci Pract. 2016;4(2):284\u201399.","journal-title":"Global Health Sci Pract"},{"key":"1240_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.socscimed.2014.09.046","volume":"121","author":"N Spicer","year":"2014","unstructured":"Spicer N, Bhattacharya D, Dimka R, Fanta F, Mangham-Jefferies L, Schellenberg J, et al. \u201cScaling-up is a craft not a science\u201d: catalysing scale-up of health innovations in Ethiopia, India and Nigeria. Soc Sci Med. 2014;121:30\u20138.","journal-title":"Soc Sci Med"},{"key":"1240_CR16","unstructured":"Fixsen A, Lundgren R, Igras S, Jennings V, Sinai I. Monitoring and evaluating scale-up of health system innovations. 2013."},{"key":"1240_CR17","volume-title":"Interpretative phenomenological analysis: theory, method and research","author":"JA Smith","year":"2009","unstructured":"Smith JA, Flowers P, Larkin M. Interpretative phenomenological analysis: theory, method and research. London: SAGE; 2009."},{"issue":"6","key":"1240_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"key":"1240_CR19","volume-title":"The Delphi method","author":"HA Linstone","year":"1975","unstructured":"Linstone HA, Turoff M. The Delphi method. MA: Addison-Wesley Reading; 1975."},{"key":"1240_CR20","unstructured":"Zimbabwe Ministry of Health and Child Care. Implementation Plan for HIV Pre-Exposure Prophylaxis in Zimbabwe 2018\u20132020. Ministry of Health and Child Care, Harare; 2018."},{"key":"1240_CR21","unstructured":"Zambia Ministry of Health. Zambia consolidated guidelines for treatment and prevention of HIV infection. Ministry of Health, Lusaka; 2018."},{"key":"1240_CR22","unstructured":"South Africa National Department of Health. PrEP Implementation Pack: South Africa 2016\u20132017. National Department of Health, Pretoria; 2019."},{"key":"1240_CR23","unstructured":"National AIDS STI Control Programme. Framework for the implementation of pre-exposure prophylaxis of HIV in Kenya. Ministry of Health, Nairobi; 2017."},{"key":"1240_CR24","unstructured":"The Health Policy Project, Health Policy Plus, The Knowledge for Health Project, SUCCESS K. Costed implementation plans: family planning 2030; 2022 [cited 2023 August 2]. Available from: https:\/\/fp2030.org\/cip."},{"key":"1240_CR25","unstructured":"PEPFAR Scientific Advisory Board. PrEP ring procurement and price. 2022."},{"key":"1240_CR26","doi-asserted-by":"crossref","unstructured":"Henderson M, Schmidt H-MA, Chitembo L, Peralta H, Alaama AS, Johnson C, et al. The future of pre-exposure prophylaxis (PrEP) for HIV prevention: a global qualitative consultation on provider perspectives on new products and differentiated service delivery. AIDS Behav. 2023:1\u201312.","DOI":"10.1007\/s10461-023-04093-1"},{"issue":"2","key":"1240_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210497","volume":"14","author":"G Meyer-Rath","year":"2019","unstructured":"Meyer-Rath G, van Rensburg C, Chiu C, Leuner R, Jamieson L, Cohen S. The per-patient costs of HIV services in South Africa: systematic review and application in the South African HIV investment case. PLoS ONE. 2019;14(2): e0210497.","journal-title":"PLoS ONE"},{"issue":"7","key":"1240_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/apc.2017.0075","volume":"31","author":"A van der Straten","year":"2017","unstructured":"van der Straten A, Shapley-Quinn MK, Reddy K, Cheng H, Etima J, Woeber K, et al. Favoring \u201cPeace of Mind\u201d: a qualitative study of African women\u2019s HIV prevention product formulation preferences from the MTN-020\/ASPIRE trial. AIDS Patient Care STDS. 2017;31(7):305\u201314.","journal-title":"AIDS Patient Care STDS"},{"key":"1240_CR29","unstructured":"Hamilton E, Kemigisha D, Chauke H, Chitukuta M, Matambanadzo K, Etima J, et al. Acceptability of CAB-LA in cisgender female adolescents in South Africa, Uganda, and Zimbabwe (HPTN 084-01). IAS 2023, the 12th IAS Conference on HIV Science; July 23\u201326; Brisbane, Australia: International AIDS Society; 2023."},{"issue":"5","key":"1240_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26088","volume":"26","author":"NJ Wara","year":"2023","unstructured":"Wara NJ, Mvududu R, Marwa MM, G\u00f3mez L, Mashele N, Orrell C, et al. Preferences and acceptability for long-acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya. J Int AIDS Soc. 2023;26(5): e26088.","journal-title":"J Int AIDS Soc"},{"key":"1240_CR31","unstructured":"Delany-Moretlwe S, Hanscom B, Angira F, Dadabhai S, Gadama D, Mirembe B, et al. Initial PrEP product choice: results from the HPTN 084 open-label extension. IAS 2023, the 12th IAS Conference on HIV Science; July 23\u201326; Brisbane, Australia: International AIDS Society; 2023."},{"key":"1240_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25296","volume":"22","author":"DA Roberts","year":"2019","unstructured":"Roberts DA, Barnabas RV, Abuna F, Lagat H, Kinuthia J, Pintye J, et al. The role of costing in the introduction and scale-up of HIV pre-exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya. J Int AIDS Soc. 2019;22: e25296.","journal-title":"J Int AIDS Soc"},{"key":"1240_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26103","volume":"26","author":"C Celum","year":"2023","unstructured":"Celum C, Grinsztejn B, Ngure K. Preparing for long-acting PrEP delivery: building on lessons from oral PrEP. J Int AIDS Soc. 2023;26: e26103.","journal-title":"J Int AIDS Soc"},{"key":"1240_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26106","volume":"26","author":"G Meyer-Rath","year":"2023","unstructured":"Meyer-Rath G, Jamieson L, Pillay Y. What will it take for an injectable ARV to change the face of the HIV epidemic in high-prevalence countries? Considerations regarding drug costs and operations. J Int AIDS Soc. 2023;26: e26106.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"1240_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25875","volume":"25","author":"E Mudimu","year":"2022","unstructured":"Mudimu E, Sardinia J, Momin S, Medina-Marino A, Bezuidenhout C, Bekker LG, et al. Incremental costs of integrated PrEP provision and effective use counselling in community-based platforms for adolescent girls and young women in South Africa: an observational study. J Int AIDS Soc. 2022;25(2): e25875.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"1240_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249625","volume":"16","author":"V Wanga","year":"2021","unstructured":"Wanga V, Peebles K, Obiero A, Mogaka F, Omollo V, Odoyo JB, et al. Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya. PLoS ONE. 2021;16(4): e0249625.","journal-title":"PLoS ONE"},{"key":"1240_CR37","unstructured":"HIV Prevention Trials Network. HPTN 084 study demonstrates superiority of injectable cabotegravir to oral FTC\/TDF for the prevention of hiv in cisgender women in sub-Saharan Africa 2020 [cited 2023 September 6]. Available from: https:\/\/www.hptn.org\/news-and-events\/press-releases\/hptn-084-study-demonstrates-superiority-of-cab-la-to-oral-tdfftc-for."},{"issue":"4","key":"1240_CR38","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/COH.0000000000000733","volume":"17","author":"MA Spinelli","year":"2022","unstructured":"Spinelli MA, Grinsztejn B, Landovitz RJ. Promises and challenges: cabotegravir for preexposure prophylaxis. Curr Opin HIV AIDS. 2022;17(4):186\u201391.","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Health Research Policy and Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12961-024-01240-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12961-024-01240-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12961-024-01240-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T12:03:11Z","timestamp":1732536191000},"score":1,"resource":{"primary":{"URL":"https:\/\/health-policy-systems.biomedcentral.com\/articles\/10.1186\/s12961-024-01240-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1240"],"URL":"https:\/\/doi.org\/10.1186\/s12961-024-01240-5","relation":{},"ISSN":["1478-4505"],"issn-type":[{"value":"1478-4505","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Columbia University\u2019s ethics committee reviewed and approved the protocol (#AAAU1602).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}